Profile data is unavailable for this security.
About the company
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
- Revenue in JPY (TTM)1.50tn
- Net income in JPY186.05bn
- Incorporated2005
- Employees17.44k
- LocationDaiichi Sankyo Co LtdDaiichi Sankyo Bldg. A/B Kan3-5-1, Nihombashi Hon-choCHUO-KU 103-8426JapanJPN
- Phone+81 362251111
- Websitehttps://www.daiichisankyo.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Co Ltd | 749.46bn | 45.42bn | 1.81tn | 11.08k | 38.47 | 2.14 | 20.94 | 2.41 | 158.37 | 158.37 | 2,613.15 | 2,852.93 | 0.585 | 1.11 | 4.00 | 67,665,220.00 | 3.65 | 5.94 | 4.86 | 8.12 | 78.95 | 75.43 | 6.23 | 9.58 | 1.79 | -- | 0.1648 | 68.53 | -1.56 | 4.41 | 15.59 | 1.35 | 6.92 | 1.30 |
| Shionogi & Co Ltd | 425.16bn | 154.46bn | 2.15tn | 5.68k | 13.76 | 1.75 | 12.62 | 5.07 | 527.99 | 527.99 | 1,453.13 | 4,149.67 | 0.3244 | 0.9783 | 2.67 | 74,851,410.00 | 11.69 | 13.45 | 13.23 | 15.20 | 85.87 | 83.95 | 36.02 | 38.01 | 6.01 | -- | 0.008 | 25.23 | 27.32 | 4.36 | 61.99 | 11.18 | 16.93 | 10.49 |
| Astellas Pharma Inc | 1.54tn | 4.20bn | 2.67tn | 14.48k | 597.79 | 1.76 | 19.58 | 1.73 | 2.47 | 2.47 | 856.92 | 838.41 | 0.5247 | 1.45 | 3.26 | 106,553,700.00 | 0.1427 | 6.93 | 0.2087 | 9.72 | 81.76 | 79.67 | 0.272 | 11.41 | 0.7143 | 130.30 | 0.3669 | 56.13 | 17.16 | 3.15 | -20.45 | -9.73 | 17.06 | 10.76 |
| Otsuka Holdings Co Ltd | 2.02tn | 121.61bn | 3.53tn | 34.39k | 28.21 | 1.43 | 15.79 | 1.75 | 224.09 | 224.09 | 3,719.71 | 4,410.81 | 0.6246 | 2.58 | 4.50 | 58,699,780.00 | 3.88 | 4.80 | 4.85 | 5.88 | 69.72 | 68.21 | 6.22 | 8.36 | 1.61 | -- | 0.0808 | 42.16 | 16.14 | 9.33 | -9.18 | 8.07 | 9.27 | 1.92 |
| Takeda Pharmaceutical Co Ltd | 4.17tn | 178.22bn | 6.53tn | 49.10k | 36.60 | 0.9606 | 7.41 | 1.57 | 112.79 | 112.79 | 2,647.34 | 4,297.22 | 0.3007 | 1.29 | 5.86 | 84,917,990.00 | 1.29 | 1.79 | 1.54 | 2.14 | 67.52 | 68.57 | 4.28 | 6.81 | 0.5518 | 2.83 | 0.4089 | 121.86 | 12.85 | 17.87 | 37.80 | 11.15 | 37.64 | 0.00 |
| Chugai Pharmaceutical Co Ltd | 1.11tn | 325.47bn | 8.65tn | 7.60k | 26.04 | 5.21 | -- | 7.78 | 197.80 | 197.80 | 675.40 | 988.01 | 0.5846 | 1.46 | 2.67 | 146,155,400.00 | 17.12 | 19.29 | 21.06 | 23.91 | 62.81 | 63.55 | 29.29 | 28.39 | 3.79 | -- | 0.0082 | 40.14 | -11.78 | 13.90 | -13.08 | 28.61 | -0.8947 | 27.23 |
| Daiichi Sankyo Co Ltd | 1.50tn | 186.05bn | 9.02tn | 17.44k | 47.78 | 5.60 | 35.82 | 6.00 | 96.97 | 96.97 | 783.61 | 827.32 | 0.5306 | 1.27 | 3.69 | 86,232,860.00 | 6.59 | 4.43 | 8.11 | 5.40 | 72.28 | 66.08 | 12.41 | 9.13 | 2.84 | -- | 0.0603 | 53.12 | 22.36 | 5.89 | 62.63 | 13.68 | 12.13 | 5.15 |
Data as of Apr 23 2024. Currency figures normalised to Daiichi Sankyo Co Ltd's reporting currency: Japanese Yen JPY
27.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Mar 2023 | 101.05m | 5.19% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 73.14m | 3.76% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 66.03m | 3.39% |
| Wellington Management Co. LLPas of 28 Mar 2024 | 61.97m | 3.18% |
| Asset Management One Co., Ltd.as of 15 Mar 2024 | 55.62m | 2.86% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 40.79m | 2.10% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 40.05m | 2.06% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 36.51m | 1.88% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 32.63m | 1.68% |
| Capital International Ltd.as of 04 Apr 2024 | 31.74m | 1.63% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
